首站-论文投稿智能助手
典型文献
Targeting a cryptic allosteric site of SIRT6 with small-molecule inhibitors that inhibit the migration of pancreatic cancer cells
文献摘要:
SIRT6 belongs to the conserved NAD+-dependent deacetylase superfamily and mediates multiple biological and pathological processes.Targeting SIRT6 by allosteric modulators represents a novel direction for therapeutics,which can overcome the selectivity problem caused by the structural sim-ilarity of orthosteric sites among deacetylases.Here,developing a reversed allosteric strategy AlloRe-verse,we identified a cryptic allosteric site,Pocket Z,which was only induced by the bi-directional allosteric signal triggered upon orthosteric binding of NAD+.Based on Pocket Z,we discovered an SIRT6 allosteric inhibitor named JYQ-42.JYQ-42 selectively targets SIRT6 among other histone deace-tylases and effectively inhibits SIRT6 deacetylation,with an IC50 of 2.33 μmol/L.JYQ-42 significantly suppresses SIRT6-mediated cancer cell migration and pro-inflammatory cytokine production.JYQ-42,to our knowledge,is the most potent and selective allosteric SIRT6 inhibitor.This study provides a novel strategy for allosteric drug design and will help in the challenging development of therapeutic agents that can selectively bind SIRT6.
文献关键词:
作者姓名:
Qiufen Zhang;Yingyi Chen;Duan Ni;Zhimin Huang;Jiacheng Wei;Li Feng;Jun-Cheng Su;Yingqing Wei;Shaobo Ning;Xiuyan Yang;Mingzhu Zhao;Yuran Qiu;Kun Song;Zhengtian Yu;Jianrong Xu;Xinyi Li;Houwen Lin;Shaoyong Lu;Jian Zhang
作者机构:
State Key Laboratory of Oncogenes and Related Genes,Department of Pharmacy,Renji Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200127,China;Medicinal Chemistry and Bioinformatics Center Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Nutshell Therapeutics,Shanghai 201203,China;Academy of Integrative Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;School of Pharmaceutical Sciences,Zhengzhou University,Zhengzhou 450001,China
引用格式:
[1]Qiufen Zhang;Yingyi Chen;Duan Ni;Zhimin Huang;Jiacheng Wei;Li Feng;Jun-Cheng Su;Yingqing Wei;Shaobo Ning;Xiuyan Yang;Mingzhu Zhao;Yuran Qiu;Kun Song;Zhengtian Yu;Jianrong Xu;Xinyi Li;Houwen Lin;Shaoyong Lu;Jian Zhang-.Targeting a cryptic allosteric site of SIRT6 with small-molecule inhibitors that inhibit the migration of pancreatic cancer cells)[J].药学学报(英文版),2022(02):876-889
A类:
orthosteric,AlloRe,JYQ,deace,tylases
B类:
Targeting,cryptic,allosteric,SIRT6,small,molecule,inhibitors,that,migration,pancreatic,cancer,cells,belongs,conserved,NAD+,dependent,superfamily,mediates,multiple,biological,pathological,processes,by,modulators,represents,novel,therapeutics,which,overcome,selectivity,problem,caused,structural,sim,ilarity,sites,among,deacetylases,Here,developing,reversed,strategy,we,identified,Pocket,was,only,induced,directional,signal,triggered,upon,binding,Based,discovered,named,selectively,targets,other,histone,effectively,inhibits,deacetylation,IC50,significantly,suppresses,mediated,inflammatory,cytokine,production,our,knowledge,most,potent,This,study,provides,drug,design,will,help,challenging,development,agents
AB值:
0.495724
相似文献
Targeting the Rac1 pathway for improved prostate cancer therapy using polymeric nanoparticles to deliver of NSC23766
Zean Li;Jun Huang;Tao Du;Yiming Lai;Kaiwen Li;Man-Li Luo;Dingjun Zhu;Jun Wu;Hai Huang-Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510220,China;Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Medical Research Center,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;School of Biomedical Engineering,Sun Yat-sen University,Shenzhen 518107,China;Department of Obstetrics and Gynecology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Urology,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China
Deubiquitinase ubiquitin-specific protease 3 (USP3) inhibits HIV-1 replication via promoting APOBEC3G (A3G) expression in both enzyme activity-dependent and -independent manners
Zhao Simin;Zheng Baisong;Wang Liuli;Cui Wenzhe;Jiang Chunlai;Li Zhuo;Gao Wenying;Zhang Wenyan-Center for Pathogen Biology and Infectious Diseases, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, Jilin 130021, China;College of Life Science of Jilin University, Changchun, Jilin 130012, China;Department of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130012, China;Jilin Provincial Key Laboratory on Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, Jilin 130041, China;Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, China
Parthenolide reveals an allosteric mode to inhibit the delSGylation activity of SARS-CoV-2 papain-like protease
Zhihui Zou;Huizhuang Shan;Demeng Sun;Li Xia;Yulong Shi;Jiahui Wan;Aiwu Zhou;Yunzhao Wu;Hanzhang Xu;Hu Lei;Zhijian Xu;Yingli Wu-Hongqiao International Institute of Medicine,Shanghai Tongren Hospital/Faculty of Basic Medicine,Chemical Biology Division of Shanghai Universities E-Institutes,Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education,Chinese Academy of Medical Sciences Research Unit 2019RU043,Shanghai Jiao Tong University School of Medicine(SJTU-SM),Shanghai 200025,China;Laboratory Medicine,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou,Guangdong 510000,China;Tsinghua-Peking Center for Life Sciences,Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology(Ministry of Education),Beijing Advanced Innovation Center for Structural Biology,Department of Chemistry,Tsinghua University,Beijing 100084,China;CAS Key Laboratory of Receptor Research,Drug Discovery and Design Center,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China
Inhibiting Hv1 channel in peripheral sensory neurons attenuates chronic inflammatory pain and opioid side effects
Qiansen Zhang;Yimin Ren;Yiqing Mo;Peipei Guo;Ping Liao;Yuncheng Luo;Jie Mu;Zhuo Chen;Yang Zhang;Ya Li;Linghui Yang;Daqing Liao;Jie Fu;Juwen Shen;Wei Huang;Xuewen Xu;Yanyan Guo;Lianghe Mei;Yunxia Zuo;Jin Liu;Huaiyu Yang;Ruotian Jiang-Shanghai Key Laboratory of Regulatory Biology,Institute of Biomedical Sciences,School of Life Sciences,East China Normal University,Shanghai,China;Laboratory of Anesthesia and Critical Care Medicine,National-Local Joint Engineering Research Center of Translational Medicine of Anesthesiology,West China Hospital,Sichuan University,Chengdu,Sichuan,China;Department of Anesthesiology,the Affiliated Hospital of Guizhou Medical University,Guiyang,Guizhou,China;Department of Integrated Traditional Chinese and Western Medicine,Sichuan Provincial Pancreatitis Centre and West China-Liverpool Biomedical Research Centre,West China Hospital,Sichuan University,Chengdu,Sichuan,China;Department of Burn and Plastic Surgery,West China Hospital of Sichuan University,Chengdu,Sichuan,China;Suzhou Institute of Drug Innovation,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Suzhou,Jiangsu,China
Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase(NAMPT)and their preclinical neuroprotective activity
Hong Yao;Minghui Liu;Leibo Wang;Yumeng Zu;Chou Wu;Chenyu Li;Ruoxi Zhang;Haigen Lu;Feifei Li;Shuang Xi;Shuangquan Chen;Xuanyu Gu;Tianya Liu;Jie Cai;Shirong Wang;Maojun Yang;Guo-Gang Xing;Wei Xiong;Lan Hua;Yefeng Tang;Gelin Wang-School of Pharmaceutical Sciences,Beijing Advanced Innovation Center for Structural Biology,Ministry of Education Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology,Tsinghua University,Beijing,China;Joint Graduate Program of Peking-Tsinghua-NIBS,School of Life Sciences,Peking University,Beijing,China;Joint Graduate Program of Peking-Tsinghua-NIBS,School of Life Sciences,Tsinghua University,Beijing,China;Tsinghua-Peking Joint Center for Life Sciences,Tsinghua University,Beijing,China;Ministry of Education Key Laboratory of Protein Science,Tsinghua-Peking Joint Center for Life Sciences,Beijing Advanced Innovation Center for Structural Biology,School of Life Sciences,Tsinghua University,Beijing,China;Neuroscience Research Institute,Peking University,Beijing,China;Beijing Advanced Innovation Center for Intelligent Robots and System,Beijing Institute of Technology,Beijing,China;School of Life Sciences,Tsinghua University,Beijing,China;GHDDI,Beijing,China
Structural basis of the activation of metabotropic glutamate receptor 3
Wei Fang;Fan Yang;Chanjuan Xu;Shenglong Ling;Li Lin;Yingxin Zhou;Wenjing Sun;Xiaomei Wang;Peng Liu;Philippe Rondard;Pan Shi;Jean-Philippe Pin;Changlin Tian;Jianfeng Liu-The First Affiliated Hospital of USTC,School of Life Sciences,Division of Life Sciences and Medicine,Joint Center for Biological Analytical Chemistry,Anhui Engineering Laboratory of Peptide Drug,Anhui Laboratory of Advanced Photonic Science and Technology,University of Science and Technology of China,Hefei,Anhui,China;Key Laboratory of Molecular Biophysics of MOE,International Research Center for Sensory Biology and Technology of MOST,College of Life Science and Technology,Huazhong University of Science and Technology(HUST),Wuhan,Hubei,China;Bioland Laboratory,Guangzhou Regenerative Medicine and Health Guangdong Laboratory,Guangzhou,Guangdong,China;Institut de Génomique Fonctionnelle(IGF),Université de Montpellier,CNRS,INSERM,Montpellier,France
Structures of the endogenous peptide-and selective non-peptide agonist-bound SSTR2 signaling complexes
Li-Nan Chen;Wei-Wei Wang;Ying-Jun Dong;Dan-Dan Shen;Jia Guo;Xuefei Yu;Jiao Qin;Su-Yu Ji;Huibing Zhang;Qingya Shen;Qiaojun He;Bo Yang;Yan Zhang;Qinglin Li;Chunyou Mao-Department of Biophysics and Department of Pathology of Sir Run Run Shaw Hospital,Zhejiang University,School of Medicine,Hangzhou,Zhejiang,China;Department of General Surgery,Sir Run Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;Center for Structural Pharmacology and Therapeutics Development,Sir Run Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;Liangzhu Laboratory,Zhejiang University Medical Center,Hangzhou,Zhejiang,China;The Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital),Hangzhou,Zhejiang,China;Zhejiang Province Key Laboratory of Anti-Cancer Drug Research,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou,Zhejiang,China;MOE Frontier Science Center for Brain Research and Brain-Machine Integration,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;Zhejiang Provincial Key Laboratory of Immunity and Inflammatory diseases,Hangzhou,Zhejiang,China
Natural product 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose is a reversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase
Wen Li;Li-ping Liao;Ning Song;Yan-jun Liu;Yi-luan Ding;Yuan-yuan Zhang;Xiao-ru Zhou;Zhong-ya Sun;Sen-hao Xiao;Hong-bo Wang;Jing Lu;Nai-xia Zhang;Hua-liang Jiang;Kai-xian Chen;Chuan-peng Liu;Jie Zheng;Ke-hao Zhao;Cheng Luo-School of Pharmacy,Key Laboratory of Molecular Pharmacology and Drug Evaluation(Yantai University),Ministry of Education,Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong,Yantai University,Yantai 264005,China;Drug Discovery and Design Center,the Center for Chemical Biology,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Center of Immunological Diseases,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Gastroenterology,Xinhua Hospital,School of Medicine,Shanghai Jiaotong University,Shanghai 201210,China;Department of Analytical Chemistry,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;School of Life Science and Technology,Shanghai Tech University,Shanghai 201210,China;School of Life Science and Technology,Harbin Institute of Technology,Harbin 200092,China;Department of Pharmacology,College of Pharmacy,Fujian Medical University,Fuzhou 350108,China
Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells
Hong Yu;Hong-ying Gao;Hua Guo;Gui-zhen Wang;Yi-qing Yang;Qian Hu;Li-jun Liang;Qun Zhao;Da-wei Xie;Yu Rao;Guang-biao Zhou-School of Chinese Materia Medica,Beijing University of Chinese Medicine,Beijing 100029,China;State Key Laboratory of Molecular Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;MOE Key Laboratory of Protein Sciences,School of Pharmaceutical Sciences,MOE Key Laboratory of Bioorganic Phosphorus Chemistry&Chemical Biology,and School of Medicine and Collaborative Innovation Center of Biotherapy,Tsinghua University,Beijing 100084,China;Hubei University of Medicine,Shiyan 442000,China
Discovery of novel MIF inhibitors that attenuate microglial inflammatory activation by structures-based virtual screening and in vitro bioassays
Yu Zhang;Lei Xu;Yao Zhang;Jie Pan;Pu-qing Wang;Sheng Tian;Huan-ting Li;Bo-wen Gao;Ting-jun Hou;Xue-chu Zhen;Long-Tai Zheng-Department of Pharmacy,Hubei Clinical Research Center of Parkinson's disease,Xiangyang Key Laboratory of Movement Disorders,Xiangyang No.1 People'Hospital,Hubei University of Medicine,Xiangyang 441000,China;Institute of Bioinformatics and Medical Engineering,Jiangsu University of Technology,Changzhou 213001,China;Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences,Soochow University,Suzhou 215123,China;School of Pharmacy,Baotou Medical College,Baotou 014060,China;College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。